Industry: Pharmaceuticals, Biotechnology
Biolex is focusing on human therapeutic proteins that are hard-to-make (peptides, cell-regulatory proteins and cytotoxic proteins) in traditional expression systems. We have demonstrated, with multiple proteins, that our unique LEX SystemÔ is highly suitable for high-level and stable expression of such proteins. Often very promising therapeutic protein candidates are not developed due to low level expression in conventional systems, thereby making them unviable commercially. A second and equally important focus is monoclonal antibodies. The LEX SystemÔ has demonstrated capability for high-level expression and scale-up of ( www.biolex.com )
Biolex , Inc.
158 Credle Street
Pittsboro, North Carolina 27312
USA
Tel: (919) 542-9901
Fax: (919) 542-9910